Trial Identifier: | D9230C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05143905 |
Start Date: | December 2021 |
Primary Completion Date: | November 2022 |
Study Completion Date: | November 2022 |
Condition: | Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
US, CA | Glendale, CA, US, 91206 |